| |
Comment on this article
Inside
Autism
People afflicted with autism live in their own worlds, but ongoing
research and treatment programs at Yale have opened windows into
this baffling and often devastating illness.
November
2002
by Bruce Fellman
In a
darkened laboratory at Yale, one man after another watches scenes
from the gut-wrenching classic, Who's
Afraid of Virginia Woolf?
But this is no simple day at the movies, for while the clips play
on a video screen, each viewer's eye movements are monitored by
miniature cameras and a bank of computers that track what the person
focuses on during the film.
When Richard Burton
and Elizabeth Taylor stop their on-screen battles long enough to engage in a fiery kiss, the tracking technology reveals that the
typical viewer is riveted on the couple's eyes. But not everyone
fits this mold, and as Burton and Taylor embrace, another man's
gaze is shown to be elsewhere. He, it turns out, is intently watching
a light switch.
This particular viewer
is no prude, embarrassed by a display of passion and seeking to
avert his eyes. Rather, the man is autistic -- afflicted by a mysterious
and often devastating illness whose core symptom is an inability
to connect with the rest of the human race.
"Most of us come into
this world primed to be experts on people, but there's something
fundamentally wrong with the way people with autism engage with
others," says Fred R. Volkmar, the director of a Yale-based endeavor
aimed at finding out precisely where in the brain the problem lies
and then crafting strategies to enable the autistic to live more
normal lives.
| |
"We
can make a big difference in the lives of the autistic."
|
The University has a
long history of work with this disorder, which was first described
in the medical literature in 1943 by Johns Hopkins child psychiatrist
Leo Kanner and is characterized by failures in social development
and language skills, as well as by the presence of odd, stereotyped
behaviors and inflexibility. Yale's involvement dates from the early
1950s, and because autism often becomes obvious by the time a youngster
turns three, research and treatment programs here have, from the
outset, been under the purview of the Child Study Center. The work
began with the pioneering studies of pediatrician Sally Provence,
and it has continued under the leadership of Edward Zigler, Donald
Cohen, and, these days, Volkmar. In fact, some of the patients first
seen as children by CSC clinicians remain, nearly 50 years later,
under their care.
In
1997 this effort garnered federal recognition when it was
named a Collaborative Program of Excellence in Autism (CPEA) by
the National Institutes of Health, and this year CPEA's mission
was further validated when it was awarded a $5 million, five-year
grant through the highly competitive Studies to Advance Autism Research
and Treatment (STAART) initiative sponsored by the NIH. (The latest
round of funding comes on top of about $5 million that is already
in place.) The STAART grant is supporting investigators observing
infants to determine what goes wrong during brain development, as
well as researchers sifting through genes to learn about the inheritance
of autism, studying the strange speech patterns found in those with
the disorder, even creating computer games that teach the autistic
how to reconnect with the world.
Last summer, Lawrence
Scahill, a CPEA researcher and an associate professor at the School
of Nursing, made international news when he and a team of colleagues
from Yale and other universities announced the discovery of the
first effective drug treatment for children bedeviled by a problem
common among those with more severe autism. "These are kids who
have daily, multiple, explosive outbursts -- Richter scale tantrums,"
says Scahill. "Sometimes their aggression is directed towards others;
sometimes they injure themselves. We don't know why this happens,
but it can stop a classroom or a family in its tracks."
Clinicians, parents,
and teachers attempting to quell these emotional earthquakes were
stymied, for the available medications were either biochemical straitjackets
or not strong enough to be effective. "Many of the drug studies
had been little more than well-intentioned fishing expeditions,"
says Scahill. But a comprehensive search of the medical literature
led him to a newly available antipsychotic medication known as risperidone,
a drug that acts on two key brain chemicals which play a key role
in regulating movement and mood.
This combination enabled
the drug to work its benefits with a lesser degree of side effects.
In 1999, Scahill and his team began an investigation of 101 autistic
children, ages 5 to 17, with severe behavioral problems. The placebo-controlled
trial lasted eight weeks, and the results, released in the August
1 edition of the New
England Journal of Medicine, were called "landmark" by reviewers.
| |
"We
can help these children by decreasing their aggressive behavior
50%."
|
"About 70 percent of
the children taking risperidone improved," says Scahill, "and the
average amount of change in these kids was a 50 percent decrease
in aggressive behavior. We didn't really see a change in autism
per se, and we don't know whether this is a drug that children can
take long-term. But we're hoping that by being able to turn these
behaviors down a notch, we can help these children become more available
for other interventions."
Volkmar, a professor
of child psychiatry, notes that the Scahill study exemplifies the
CPEA approach. "Because of the work we've done and continue to do,
we can make a big difference in the lives of the autistic," he says,
admitting that his optimism is of fairly recent vintage. "In the
past, people with autism tended to do very poorly."
Autism, which is now
considered one of a group of illnesses collectively known as pervasive
developmental disorders, tends to run in families and affects about
1 in 1,000 people, some far more severely than others. There are
approximately 70,000 people with full-blown autism in this country,
and while a few are categorized as autistic savants -- gifted with
an extraordinary talent for, say, music, art, determining any day
of the week throughout history, or, like the character played by
Dustin Hoffman in the 1988 film Rain
Man, counting cards -- a majority of those with the disorder
are mentally retarded. More than a third of them never speak.
They
were once considered to be both unteachable and unreachable,
and frequently, being diagnosed as autistic was the first step on
a grim road that led to institutionalization and a life spent rocking
aimlessly in the back wards of mental hospitals. Doubly tragic,
some psychiatrists during the 1950s and 1960s blamed autism on parental
failure. Indeed, the suggestion that the disorder resulted from
a lack of maternal warmth towards a child had people calling it
the "refrigerator mother" syndrome.
"There's absolutely
no evidence that mothers or fathers cause it," says Volkmar. "And
I've seen kids with autism in every educational, social, and economic
situation, and on every continent except Antarctica. Autism is everywhere."
In the 1970s, researchers
began to view autism as the result of brain development gone awry
rather than a problem of parenting, and given what has been learned
about the brain's often remarkable ability to overcome damage, clinicians,
teachers, and parents alike adopted a new way of working with the
autistic. The strategy was called "early intervention," and it involved
identifying youngsters with the disorder as quickly as possible
and then enrolling them in intensive training programs that would
maximize their skills and teach them how to engage with the world.
"Early intervention
is clearly important," notes Volkmar, citing Educating Children
with Autism, a book-length study published last year by the
National Academy of Sciences that documents the effectiveness of
the strategy. "And the earlier you intervene, the better."
One reason Volkmar
and his colleagues are watching people watch Who's Afraid of
Virginia Woolf? is to develop techniques that can be used to
identify children with autism who are far too young to see such
movies. The analysis of eye movements is emerging as a powerful
screening technique -- and it also provides a window through which
researchers and parents alike can glimpse how the universe appears
through an autistic lens.
| |
"Just
making basic contact was difficult. That got me interested
in autism's communications breakdown."
|
"Because we share a
common background as human beings, we take it for granted that we
all see a scene in the same way," says Ami Klin, the Harris Associate
Professor of Child Psychiatry and the director of the vision-tracking
project. "But one of the most eye-opening features of this research
is that the world can look very different from the viewpoint of
another person, especially someone with autism."
Much of the impetus
for this approach -- and a good deal of the technological expertise
-- actually came from an undergraduate, Warren Jones, an art and engineering dual major who graduated in 1999 and developed the eye-tracking
approach for his senior thesis. At the behest of his grandmother,
Jones, now a CPEA research associate, had spent many of his summers
working with kids with special needs, and when he came to Yale,
he continued this endeavor by volunteering to teach art at Benhaven,
a local school for children and adults with autism. "Many of them
were non-verbal, so just making basic contact was difficult," says
Jones. "That got me interested in the nature of the communications
breakdown in autism."
To better understand
the disorder, he enrolled in Volkmar's year-long seminar on autism,
and in short order, Jones turned his engineering skills towards
creating devices that would enable him to see what the autistic
were seeing and, perhaps, break through the communications barrier.
As it happened, Jones learned that much of the eye-tracking software
and hardware had already been created by U.S. military researchers,
and for his senior thesis, he adopted this technology -- the tiny
cameras are housed in a baseball cap worn by viewers -- to begin examining rigorously a phenomenon that anyone who has ever known
an autistic person quickly observes: People with autism rarely look
anyone in the eye.
Normal infants, almost
as soon as they open their eyes after birth, instinctively focus
on the human face, a familiar one in particular, and as children
grow, their gaze will increasingly be directed to the eyes of other
people. But a hallmark of autism is that neither the human face
nor the eyes have any special allure.
The two Virginia
Woolf studies that have been completed to date make this starkly
clear. The most recent paper, published in September in the Archives
of General Psychiatry, compared 15 adolescent and young adult
males who had autism with age-matched, non-autistic counterparts.
Members of the latter group spent about two-thirds of their viewing
time watching the eyes of the actors; by contrast, those with autism
watched eyes less than 25 percent of the time. Instead, they focused
more of their attention (41.2 percent) on the actors' mouths.
The
lack of eye contact has profound implications, says Klin.
"This movie portrays socializing as a contact sport, but if you're
spending your time watching mouths, you're missing most of the social
action," he notes. "When you're not looking at a person's eyes,
social interactions -- even something as basic as buying a candy
bar or driving -- become difficult or impossible."
Using images more appropriate
for youngsters, CPEA scientist Katarzyna Chawarska, a clinician
at the Child Study Center who earned her doctorate in psychology
in 2000, has shown just how early this deficit emerges. As a postdoctoral
researcher, Chawarska helped start a CSC clinic for children under
3. "We quickly got many, many referrals," she says, explaining that
a common reason parents cite for concern is a child's difficulty
in learning to talk and interact.
| |
"Autistic
infants may pay more attention to objects than to faces
and eyes."
|
Chawarska was interested
in how infants and young children learn to read eye movements as
a source of information about other people, and although she now
had plenty of research subjects, she needed a new way to watch them
watch the world. "Babies had difficulty wearing the baseball cap,"
she laughs. But a hat-free method to monitor eye movements was soon
developed, and Chawarska learned how to visually engage the youngsters, even those who were severely impaired. In her experiments, an adult
appears on a video screen. The child looks as the adult's computer-generated eyes move either to the right or left.
This tendency to follow
another person's eye movements is called "gaze monitoring," says
Chawarska. "It has a huge survival value, and we're probably born
with a rudimentary form of it. But the real skill doesn't emerge
until a child is more than a year old, and it then takes a couple
of years to perfect."
As each infant seated
in Chawarska's lab watches the eyes move, another image -- Barney,
Mickey Mouse, or some other popular icon -- pops up on the video
screen. Sometimes it appears in the space towards which the eyes
have turned; at other times, it appears in the opposite spot. There's
no predictable pattern, and the eyes may occasionally lead the infant
astray. By using a hidden eye-tracking camera, Chawarska can time
how long it takes the child to lock on to the icon, and she has
found that while children with autism are physically able to follow
the lead of the eyes, they are much faster at locating the icons
than normal children.
No one knows how they
accomplish this task, but it is possible that even at this early
an age, autistic children are simply paying more attention to objects
than faces and eyes. CPEA researcher Robert Schultz has a good idea
why this happens, and his insights may point the way towards an
innovative method to help the autistic.
"We have a tool called
functional magnetic resonance imaging (fMRI) that enables us to
see the brain at work," says Schultz, a neurobiologist.
A typical MRI shows
the body's soft tissues -- organs, muscles, tendons, and the like
-- while fMRI allows researchers to view blood flow. The theory
is that since activity in, say, the brain requires fuel, an increase
or decrease in activity will be reflected in a change in blood flow
patterns.
Using
this technique, researchers have built maps of the brain as it gets
down to business, and what they have found is that the human
brain has a special area set aside for face recognition. Known as
the fusiform gyrus, this finger-sized region on the underside of
the temporal lobes typically shows red -- a sign of high blood flow
-- in fMRI studies of normal individuals when they're given face
recognition tasks. But when Schultz used fMRI to watch people with
autism do the same job, something telling -- but, given what is
known about the way the autistic view the world, hardly surprising
-- was revealed.
"The fMRI images showed
a distinct underactivation in the fusiform gyrus among people with
autism, and the more severely disabled they were, the less activity
there was in the fusiform," says Schultz. "But when they were looking
at faces, what actually lit up more was the area involved in the
recognition of objects."
| |
"Why
faces have no special status to the brains of people with
autism is a mystery."
|
Why the face, in the
brain of an autistic person, has lost its special status is a mystery,
but acting on the possibility that the lack of fusiform activity
is more effect than cause, Schultz and Oberlin College researcher
James Tanaka have developed a way to change matters at the behavioral
and, they hope, brain level. "Kids with autism are drawn to computers,
and many of them get very good at using programs and at surfing
the Internet," says Schultz.
To capitalize on this
inclination, the two scientists have created a suite of computer
games called "Let's Face It." These involve a series of challenges
designed to increase interest in faces and then improve the ability
of autistic children to "understand non-verbal communication," says
Schultz, describing a six-month study that will soon get underway
with a group of 65 kids.
"Training programs
for the autistic are very expensive," he notes, "but if these games
work, we can achieve a significant result -- making face recognition
as automatic as possible -- much cheaper."
Schultz suspects that
success might even result in changes in fusiform activity, but he
has no illusions about permanently altering the core problem. "What
we're attempting to do is compensatory -- teaching skills that work
around a deficit," he says.
Still, given what has
been the lot of people with autism, the availability of re-engagement
strategies is a remarkable development. "We don't yet have a cure,"
says Fred Volkmar. "But this is a time of great hope."  |
|